Page last updated: 2024-10-23

berberine and Multiple Organ Failure

berberine has been researched along with Multiple Organ Failure in 2 studies

Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.

Research Excerpts

ExcerptRelevanceReference
" In the present study, we investigated the effects of berberine in combination with yohimbine (BY) on neutrophil tissue infiltration and multiple organ damage during sepsis, and further elucidated the involved mechanisms."5.43Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils. ( Li, H; Lu, D; Lv, X; Tang, X; Wang, F; Wang, H; Wang, Y; Yang, D, 2016)
" In the present study, we investigated the effects of berberine in combination with yohimbine (BY) on neutrophil tissue infiltration and multiple organ damage during sepsis, and further elucidated the involved mechanisms."1.43Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils. ( Li, H; Lu, D; Lv, X; Tang, X; Wang, F; Wang, H; Wang, Y; Yang, D, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Wang, F1
Yang, D1
Tang, X1
Li, H1
Lv, X1
Lu, D1
Wang, H1
Lee, DU1
Ko, YS1
Kim, HJ1
Chang, KC1

Other Studies

2 other studies available for berberine and Multiple Organ Failure

ArticleYear
Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils.
    International immunopharmacology, 2016, Volume: 35

    Topics: Animals; Antibodies, Blocking; Berberine; Cecum; Cell Movement; Cells, Cultured; Disease Models, Ani

2016
13-Ethylberberine reduces HMGB1 release through AMPK activation in LPS-activated RAW264.7 cells and protects endotoxemic mice from organ damage.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 86

    Topics: AMP-Activated Protein Kinase Kinases; Animals; Berberine; Endotoxemia; Enzyme Activation; HMGB1 Prot

2017